Water-soluble fullerenes for medical applications

References

• R. Taylor and D. R. M. Walton: Nature, 1993, 363, (6431), 685–693.
   Web of Science ®Google Scholar
• K. M. Kadish and R. S. Ruoff: ‘Fullerenes: chemistry, physics, and technology’, 2000, New York, Wiley.
   Google Scholar
• R. C. Haddon, R. E. Palmer, H. W. Kroto and P. A. Sermon: ‘The fullerenes: powerful carbon-based electron acceptors’, Philos. Trans. R. Soc. A: Math. Phys. Eng. Sci., 1993, 343, (1667), 53–62.
   Web of Science ®Google Scholar
• P. W. Fowler and D. E. Manolopoulos: ‘An Atlas of fullerenes’, ‘Dover books on chemistry’, 2006, New York, Dover Publications.
   Google Scholar
• Q. Xie, E. Perez-Cordero and L. Echegoyen: ‘Electrochemical detection of C606- and C706-: enhanced stability of fullerides in solution’, J. Am. Chem. Soc., 1992, 114, (10), 3978–3980.
   Web of Science ®Google Scholar
• M. P. Gasper and D. W. Armstrong: ‘A comparative study of buckminsterfullerene and higher fullerene separations by HPLC’, J. Liq. Chromatogr., 1995, 18, (6), 1047–1076.
   Web of Science ®Google Scholar
• F. Diederich, R. Ettl, Y. Rubin, R. L. Whetten, R. Beck, M. Alvarez, S. Anz, D. Sensharma, F. Wudl, K. C. Khemani and A. Koch: ‘The Higher Fullerenes: Isolation and Characterization of C76, C84, C90, C94, and C70O, an Oxide of D5h-C70’, Science, 1991, 252, (5005), 548–551.
   PubMed Web of Science ®Google Scholar
• F. Cataldo and T. Da Ros: ‘Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes, ‘Carbon materials: chemistry and physics’, 2008, Berlin, Springer Science+Business Media.
   Google Scholar
• K. N. Semenov, N. A. Charykov, V. A. Keskinov, A. K. Piartman, A. A. Blokhin and A. A. Kopyrin: ‘Solubility of light fullerenes in organic solvents’, J. Chem. Eng. Data, 2010, 55, (1), 13–36.
   Web of Science ®Google Scholar
• X. Zhou, J. Liu, Z. Jin, Z. Gu, Y. Wu and Y. Sun: ‘Solubility of fullerene C60 and C70 in toluene, o-xylene and carbon disulfide at various temperatures’, Fullerene Sci. Technol., 1997, 5, (1), 285–290.
   Web of Science ®Google Scholar
• C. Bingel and H. Schiffer: ‘Biscyclopropanation of C70’, Liebigs Ann., 1995, 1551–1553.
   Google Scholar
• N. S. Goroff: ‘Mechanism of fullerene formation’, Acc. Chem. Res., 1996, 48824, (8), 77–83.
   Web of Science ®Google Scholar
• H. Murayama, S. Tomonoh, J. M. Alford and M. E. Karpuk: ‘Fullerene production in tons and more: from science to industry’, Fuller. Nanotub. Car. N., 2005, 12, (February 2015), 1–9.
   Web of Science ®Google Scholar
• W. Kratschmer, L. D. Lamb, K. Fostiropoulos and D. R. Huffman: ‘Solid C60: a new form of carbon’, Nature, 1990, 347, 354–358.
   Web of Science ®Google Scholar
• H. W. Kroto, J. R. Heath, S. C. O'Brien, R. F. Curl and R. E. Smalley: ‘C60: buckminsterfullerene’, Nature, 1985, 318, (6042), 162–163.
   Web of Science ®Google Scholar
• A. Hirsch, M. Brettreich and F. Wudl: ‘Fullerenes: chemistry and reactions’, 2006, Weinheim, Wiley.
   Google Scholar
• M. Maggini, G. Scorrano and M. Prato: ‘Addition of azomethine ylides to C60: synthesis, characterization, and functionalization of fullerene pyrrolidines’, J. Am. Chem. Soc., 1993, 115, (21), 9798–9799.
   Web of Science ®Google Scholar
• C. Bingel: ‘Cyclopropanierung von fullerenen’, Chemische Berichte, 1993, 126, (8), 1957–1959.
   Google Scholar
• V. Georgakilas, K. Kordatos, M. Prato, D. M. Guldi, M. Holzinger and A. Hirsch: ‘Organic functionalization of carbon nanotubes’, J. Am. Chem. Soc., 2002, 124, (5), 760–761.
   PubMed Web of Science ®Google Scholar
• K. S. Coleman, S. R. Bailey, S. Fogden and M. L. H. Green: ‘Functionalization of single-walled carbon nanotubes via the bingel reaction’, J. Am. Chem. Soc., 2003, 125, (29), 8722–8723.
   PubMed Web of Science ®Google Scholar
• F. Wudl, A. Hirsch, K. C. Khemani, T. Suzuki, P-M. Allemand, A. Koch, H. Eckert, G. Srdanov and H. M. Webb: ‘Survey of chemical reactivity of C60, electrophile, and dienopolarophile par excellence’ in ‘Synthesis, properties, and chemsitry of large carbon clusters’, (ed. G. S. Hammond and V. J. Kuck), chap. 11, ACS Symposium Series 481, 161–176; 1992, Washington, DC, American Chemical Society.
   Google Scholar
• R. Seshadri, A. Govindaraj, R. Nagarajan, T. Pradeep and C. N. R. Rao: ‘Addition of amines and halogens to fullerenes C60 and C70’, Tetrahedron Lett., 1992, 33, (15), 2069–2070.
   Web of Science ®Google Scholar
• V. Brezova, A. Stasko, P. Rapta, G. Domschke, A. Bartl and L. Dunsch: ‘Fullerene anion formation by electron transfer from amino donor to photoexcited C60. Electron paramagnetic resonance study’, J. Phys. Chem., 1995, 99, (44), 16234–16241.
   Web of Science ®Google Scholar
• O. Amelines-Sarria and V. A. Basiuk: ‘A DFT study of methylamine polyaddition to C80 fullerene’, Superlattice Microst., 2009, 46, (1–2), 302–305.
   Google Scholar
• L. Y. Chiang, J. W. Swirczewski, C. S. Hsu, S. K. Chowdhury, S. Cameron and K. Creegan: ‘Multi-hydroxy additions onto C60 fullerene molecules’, J. Chem. Soc. Chem. Commun., 1992, 1791–1793.
   Google Scholar
• J. Li, A. Takeuchi, M. Ozawa, X. Li, K. Saigo and K. Kitazawa: ‘C60 fullerol formation catalysed by quaternary ammonium hydroxides’, J. Chem. Soc. Chem. Commun., 1993, 1784–1785.
   Google Scholar
• N. S. Schneider, A. D. Darwish, H. W. Kroto, R. Taylor and D. R. M. Walton: ‘Formation of fullerols via hydroboration of fullerene-C60’, J. Chem. Soc. Chem. Commun., 1994, 463–464.
   Google Scholar
• A. Arrais and E. Diana: ‘Highly water soluble C60 derivatives: a new synthesis’, Fullerene Nanotub. Carb. N., 2003, 11, (1), 35–46.
   Web of Science ®Google Scholar
• F. Scarel: ‘Fullerene-stoppered rotaxane : a multifunctional supramolecular material’, PhD thesis, Freiburg Institute of Advanced Studies, 2012.
   Google Scholar
• C. M. Cardona, B. Elliott and L. Echegoyen: ‘Unexpected chemical and electrochemical properties of M3N@C80 (M = Sc, Y, Er)’, J. Am. Chem. Soc., 2006, 128, (19), 6480–6485.
   PubMed Web of Science ®Google Scholar
• D. Milic and M. Prato: ‘Fullerene unsymmetrical bis-adducts as models for novel peptidomimetics’, Eur. J. Org. Chem., 2010, 476–483.
   Web of Science ®Google Scholar
• N. Chhabra, M. L. Aseri and D. Padmanabhan: ‘A review of drug isomerism and its significance’, Int. J. Appl. Basic Med. Res., 2013, 3, (1), 16–18.
   PubMedGoogle Scholar
• Q. Lu, D. I. Schuster and S. R. Wilson: ‘Preparation and characterization of six bis(N-methylpyrrolidine)-C60 isomers: magnetic deshielding in isomeric bisadducts of C60’, J. Organ. Chem., 1996, 61 (24), 4764–4768.
   PubMed Web of Science ®Google Scholar
• Z. Zhou and S. Wilson: ‘Tether-directed multiple functionalization of fullerene[60]’, Curr. Organ. Chem., 2005, 9, (8), 789–811.
   Web of Science ®Google Scholar
• J.-F. Nierengarten and J.-F. Nicoud: ‘cyciopropanation of C60 with malonic acid mono-esters’, Tetrahedron Lett., 1997, 38, (44), 7737–7740.
   Web of Science ®Google Scholar
• X. Camps and A. Hirsch: ‘Efficient cyclopropanation of C60 starting from malonates’, J. Chem. Soc. Perkin Trans. 1, 1997 (11), 1595–1596.
   Google Scholar
• A. Hirsch, I. Lamparth and H. R. Karfunkel: ‘Fullerene chemistry in three dimensions: isolation of seven regioisomeric bisadducts and chiral trisadducts of C60 and Di(ethoxycarbonyl)methylene’, Angew. Chem. Int. Ed. Engl., 1994, 33, (4), 437–438.
   Web of Science ®Google Scholar
• D. Sigwalt, F. Schillinger, S. Guerra, M. Holler, M. Berville and J-F. Nierengarten: ‘An expeditious regioselective synthesis of [60]fullerene e,e,e tris-adduct building blocks’, Tetrahedron Lett., 2013, 54, (32), 4241–4244.
   Web of Science ®Google Scholar
• Á. Duarte-Ruiz, L. Echegoyen, A. Aya and F. Gomez-Baquero: J. Mex. Chem. Soc., 2009, 53, (3), 169–173.
   Web of Science ®Google Scholar
• H. Li, S. A. Haque, A. Kitaygorodskiy, M. J. Meziani, M. Torres-Castillo and Y. P. Sun: ‘Alternatively modified Bingel reaction for efficient syntheses of C60 hexakis-adducts’, Org. Lett., 2006, 8, (24), 5641–5643.
   PubMed Web of Science ®Google Scholar
• I. Lamparth and A. Hirsch: ‘Water-soluble malonic acid derivatives of C60 with a defined three-dimensional structure’, J. Chem. Soc. Chem. Commun., 1994, 1727–1728.
   Google Scholar
• B. Jin, J. Shen, R. Peng, R Zheng and S. Chu: ‘Efficient cyclopropanation of [60]fullerene starting from bromo-substituted active methylene compounds without using a basic catalyst’, Tetrahedron Lett., 2014, 55, (36), 5007–5010.
   Web of Science ®Google Scholar
• Y. Chai, T. Cuo, C. Jin, R. E. Haufler, L. P. F. Chibante, J. Fure, L. Wang, J. M. Alford and R. E. Smalley: ‘Fullerenes wlth metals inside’, J. Phys. Chem., 1991, 95, (9), 7564–7568.
   Web of Science ®Google Scholar
• A. Krachmalnicoff, M. H. Levitt and R. J. Whitby: ‘An optimised scalable synthesis of H2O@C60 and a new synthesis of H2@C60’, Chem. Commun., 2014, 50, (86), 13037–13040.
   PubMed Web of Science ®Google Scholar
• A. Popov, S. Yang and L. Dunsch: Endohedral Fullerenes, Chem. Rev., 2013, 113, (8), 5989–6113.
   PubMed Web of Science ®Google Scholar
• P. Dallas, I. Rasovic, G. Rogers et al.: in ‘Carbon nanomaterials sourcebook: graphene, fullerenes, nanotubes and nanodiamonds,’ (ed. K. Sattler), chap. 10, 255–270; 2016, Boca Raton, Taylor & Francis.
   Google Scholar
• J. R. Heath, S. C. O'Brien, Q. Zhang, Y. Liu, R. F. Curl, F. K. Tittel and R. E. Smalley: ‘Lanthanum complexes of spheroidal carbon shells’, J. Am. Chem. Soc., 1985, 107, (25), 7779–7780.
   Web of Science ®Google Scholar
• Y. Saito, S. Yokoyama, M. Inakuma and H. Shinohara: ‘An ESR study of the formation of La@C82 isomers in arc synthesis’, Chem. Phys. Lett., 1996, 250, (1), 80–84.
   Web of Science ®Google Scholar
• H. Shinohara: ‘Endohedral metallofullerenes’, Rep. Prog. Phys., 2000, 63, (6), 843–892.
   Web of Science ®Google Scholar
• V. S. Kozlov, M. V. Suyasova and V. T. Lebedev: ‘Synthesis, extraction, and chromatographic purification of higher empty fullerenes and endohedral gadolinium metallofullerenes’, Russ. J. Appl. Chem., 2014, 87, (2), 121–127.
   Web of Science ®Google Scholar
• S. Stevenson, G. Rice, T. Glass, K. Harich, F. Cromer, M. R. Jordan, J. Craft and H. C. Dorn: ‘Metallofullerenes in high yield and purity’, Nature, 1999, 80, 80–82.
   Google Scholar
• L. Dunsch, M. Krause, J. Noack and P. Georgi: ‘Endohedral nitride cluster fullerenes: formation and spectroscopic analysis’, J. Phys. Chem. Solids, 2004, 65, 309–315.
   Web of Science ®Google Scholar
• V. Bezmelnitsyn, S. Davis and Z. Zhou: ‘Efficient synthesis of endohedral metallofullerenes in 3-phase arc discharge’, Fullerene Nanotub. Carb. N., 2014, 23, 612–617.
   Web of Science ®Google Scholar
• Q. Deng and A. A. Popov: ‘Prato and bingel-hirsch cycloaddition to heptagon-containing LaSc2N@Cs(hept)-C80: importance of pentalene units’, Chem. Commun., 2015, 51, (26), 5637–5640.
   PubMed Web of Science ®Google Scholar
• V. K. Koltover: ‘Spin-leakage of the fullerene shell of endometallofullerenes: EPR, ENDOR and NMR evidences’, Carbon, 2004, 42, 1179–1183.
   Web of Science ®Google Scholar
• B. Cao, T. Wakahara, Y. Maeda, A. Han, T. Akasaka, T. Kato, K. Kobayashi and S. Nagase: ‘Lanthanum endohedral metallofulleropyrrolidines: synthesis, isolation, and EPR characterization’, Chem. Eur. J., 2004, 10, (3), 716–720.
   PubMed Web of Science ®Google Scholar
• R. Bolskar, A. Benedetto, L. Husebo, R. Price, E. Jackson, S. Wallace, L. Wilson and M. Alford: ‘First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60 [C(COOH)2]10 as a MRI contrast agent’, J. Am. Chem. Soc., 2003, 125, (18), 5471–5478.
   PubMed Web of Science ®Google Scholar
• S. Kunsági-Máté, K. Szabó, I. Bitter, G. Nagy and L. Kollar: ‘Complex formation between water-soluble sulfonated calixarenes and C60 fullerene’, Tetrahedron Lett., 2004, 45, (7), 1387–1390.
   Web of Science ®Google Scholar
• F. Giacalone, N. Martín and F. Wudl: in ‘Fullerene polymers,’ chap. 1, 1–14; 2009, Weinheim, Wiley-VCH.
   Google Scholar
• Y. Iwamoto and Y. Yamakoshi: ‘A highly water-soluble C60-NVP copolymer: a potential material for photodynamic therapy’, Chem. Commun., 2006, 4805–4807.
   PubMed Web of Science ®Google Scholar
• F. Beuerle, R. Lebovitz and A. Hirsch: in ‘Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes’, (ed. F. Cataldo & T. Da Ros), Vol. 1, chap. 3, 51–78; 2008, Berlin, Springer Science+Business Media.
   Google Scholar
• M. Brettreich and A. Hirsch: ‘A highly water-soluble dendro[60]-fullerene’, Tetrahedron Lett., 1998, 39, (18), 2731–2734.
   Web of Science ®Google Scholar
• T. Da Ros, M. Prato, F. Novello, M. Maggini and E. Banfi: ‘Easy access to water-soluble fullerene derivatives via 1,3-dipolar cycloadditions of azomethine ylides to C60’, J. Organ. Chem., 1996, 61, (25), 9070–9072.
   PubMed Web of Science ®Google Scholar
• S. Aroua, W. B. Schweizer and Y. Yamakoshi: ‘C60 pyrrolidine bis-carboxylic acid derivative as a versatile precursor for biocompatible fullerenes’, Organ. Lett., 2014, 16, 1688–1691.
   PubMed Web of Science ®Google Scholar
• C. Chen, G. Xing, J. Wang, Y. Zhao, B. Li, J. Tang, G. Jia, T. Wang, J. Sun, L. Xing, H. Yuan, Z. Chen, F. Zhao, Z. Chai and X. Fang: ‘Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity’, Nano Lett., 2005, 82(10), 2050–2057.
   Web of Science ®Google Scholar
• S. Kunjachan, J. Ehling, G. Storm, F. Kiessling and T. Lammers: ‘Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects’, Chem. Rev., 2015, 115, (19), 10907–10937.
   PubMed Web of Science ®Google Scholar
• G. Hagberg and K. Scheffler: ‘Effect of r1 and r2 relaxivity of gadolinium-based contrast agents on the T1-weighted MR signal at increasing magnetic field strengths’, Contrast Media Mol. Imaging, 2013, 8, (6), 456–465.
   PubMed Web of Science ®Google Scholar
• A. J. Amoroso and S. J. A. Pope: ‘Using lanthanide ions in molecular bioimaging’, Chem. Soc. Rev., 2015, 44, 4723–4742.
   PubMed Web of Science ®Google Scholar
• P. Caravan, J. Ellison, T. McMurry and R. Lauffer: ‘Gadolinium-(III) chelates as MRI contrast agents: structure, dynamics, and applications’, Chem. Rev., 1999, 99, (9), 2293–2352.
   PubMed Web of Science ®Google Scholar
• P. Caravan: ‘Strategies for increasing the sensitivity of gadolinium based MRI contrast agents’, Chem. Soc. Rev., 2006, 35, (6), 512–523.
   PubMed Web of Science ®Google Scholar
• P. H. Kuo, E. Kanal, A. K. Abu-Alfa and S. E. Cowper: ‘Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis’, Radiology, 2007, 242, 647–649.
   PubMed Web of Science ®Google Scholar
• J. G. Penfield and R. F. Reilly: ‘What nephrologists need to know about gadolinium’, Nat. Clin. Pract. Nephrol., 2007, 3, (12), 654–668.
   PubMedGoogle Scholar
• K. Hartman and L. Wilson: ‘Carbon nanostructures as a new high-performance platform for MR molecular imaging’ in Bio-applications of nanoparticles’, (ed. W. Chan), Vol. 620, chap. 6, 74–84; 2007, New York, Springer-Verlag.
   Google Scholar
• B. Sitharaman, R. D. Bolskar, I. Rusakova and L. J. Wilson: ‘Gd@C60[C(COOH)2]10 and Gd@C60(OH)x : nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution’, Nano Lett., 2004, 4, (12), 2373–2378.
   Web of Science ®Google Scholar
• J. Zhang, C. Shu, J. Reid, L. S. Owens, T. Cai, W. Gibson, G. L. Long, F. D Corwin, Z.-J. Chen, P. P. Fatouros and H. C. Dorn: ‘High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality’, Bioconjug Chem., 2010, 21, (4), 610–615.
   PubMed Web of Science ®Google Scholar
• D. Yang, Y. Zhao, H. Guo, Y. Li, P. Tewary and G. Xing: ‘Nanoparticles, [Gd@C82(OH)22]n, induces dendritic cell maturation and activates Th1 immune responses’, ACS Nano, 2011, 4, (2), 1178–1186.
   Web of Science ®Google Scholar
• S. Laus, B. Sitharaman, É. Tóth, R. D. Bolskar, L. Helm, S. Asokan, M. S. Wong, L. J. Wilson and A. E. Merbach: ‘Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C60(OH)x and Gd@C60 [C(COOH2)]10’, J. Chem. Soc., 2005, 127, (26), 10–13.
   Web of Science ®Google Scholar
• M. Mikawa, H. Kato, M. Okumura, M. Narazaki, Y. Kanazawa, N. Miwa and H. Shinohara: ‘Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents’, Bioconjugate Chem., 2001, 12, (4), 510–514.
   PubMed Web of Science ®Google Scholar
• C. Shu, F. D. Corwin, J. Zhang, Z. Chen, J. E. Reid, M. Sun, W. Xu, J. H. Sim, C. Wang, P. P. Fatouros, R. Alan, H. W. Gibson and H. C. Dorn: ‘Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high1H relaxivity’, Bioconjug Chem., 2009, 20, (6), 1186–1193.
   PubMed Web of Science ®Google Scholar
• P. P. Fatouros, F. D. Corwin, Z.-J. Chen, W. C. Broaddus, J. L. Tatum, B. Kettenmann, Z. Ge, H. W. Gibson, J. L. Russ, A. P. Leonard, J. C. Duchamp and H. C. Dorn: ‘In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle’, Radiology, 2006, 240, (3), 756–764.
   PubMed Web of Science ®Google Scholar
• K. B. Ghiassi, M. M. Olmstead and A. L. Balch: ‘Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents’, Dalton Trans., 2014, 43, 7346–7358.
   PubMed Web of Science ®Google Scholar
• E.-Y. Zhang, C.-Y. Shu, L. Feng and C.-R. Wang: ‘Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents’, J. Phys. Chem. B, 2007, 111, 14223–14226.
   PubMed Web of Science ®Google Scholar
• R. Cui, J. Li, H. Huang, M. Zhang, X. Guo, Y. Chang, M. Li, J. Dong, B. Sun and G. Xing: ‘Novel carbon nanohybrids as highly efficient magnetic resonance imaging contrast agents’, Nano Res., 2015, 8, (4), 1259–1268.
   Web of Science ®Google Scholar
• L. Wang, X. Zhu, X. Tang, C. Wu, Z. Zhou, C. Sun, S.-L. Deng, H. Ai and J. Gao: ‘A multiple gadolinium complex decorated fullerene as a highly sensitive T1 contrast agent’, Chem. Commun., 2015, 51, (21), 4390–4393.
   PubMed Web of Science ®Google Scholar
• T. Wharton and L. J. Wilson: ‘Highly-iodinated fullerene as a contrast agent for X-ray imaging’, Bioorg. Med. Chem., 2002, 10, (11), 3545–3554.
   PubMed Web of Science ®Google Scholar
• A. Miyamoto, H. Okimoto, H. Shinohara and Y. Shibamoto: ‘Development of water-soluble metallofullerenes as x-ray contrast media’, Eur. Radiol., 2006, 16, (5), 1050–1053.
   PubMed Web of Science ®Google Scholar
• S. H. Friedman, D. L. Decamp, R. P. Sijbesma, G. Srdanov, F. Wudl and G. L. Kenyon: ‘Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification’, J. Am. Chem. Soc., 1993, 115, (5), 6506–6509.
   Web of Science ®Google Scholar
• H. Tzoupis, G. Leonis, S. Durdagi, V. Mouchlis, T. Mavromoustakos and M. G. Papadopoulos: ‘Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations’, J. Computer Aided Mol. Des., 2011, 25, (10), 959–976.
   PubMed Web of Science ®Google Scholar
• T. A. Strom, S. Durdagi, S. S. Ersoz, R. E. Salmas, C. T. Supuran and A. R. Barron: ‘Fullerene-based inhibitors of HIV-1 protease’, J. Peptide Sci., 2015, 21, (12), 862–870.
   PubMed Web of Science ®Google Scholar
• S. Tanimoto, S. Sakai, S. Matsumura, D. Takahashi and K. Toshima: ‘Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid’, Chem. Commun., 2008 (44), 5767.
   PubMed Web of Science ®Google Scholar
• A. A. Alfadda and R. M. Sallam: ‘Reactive oxygen species in health and disease’, J. Biomed. Biotechnol., 2012, 2012, 1–14.
   PubMedGoogle Scholar
• J. F. Turrens: ‘Mitochondrial formation of reactive oxygen species’, J. Physiol., 2003, 552, 335–344.
   PubMed Web of Science ®Google Scholar
• P. D. Ray, B. W. Huang and Y. Tsuji: ‘Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling’, Cell. Signal., 2012, 24, (5), 981–990.
   PubMed Web of Science ®Google Scholar
• K. Ishikawa, K. Takenaga, M. Akimoto, N. Koshikawa, A. Yamaguchi, H. Imanishi, K. Nakada, Y. Honma and J.-I. Hayashi: ‘ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis’, Science, 2008, 320, (5876), 661–664.
   PubMed Web of Science ®Google Scholar
• V. Shukla, S. K. Mishra and H. C. Pant: ‘Oxidative Stress in Neurodegeneration’, Adv. Pharmacol. Sci., 20111–13.
   Google Scholar
• B. N. Ames, M. K. Shigenaga and T. M. Hagen: ‘Oxidants, antioxidants, and the degenerative diseases of aging’, Proc. Natl. Acad. Sci. U.S.A., 1993, 90, (17), 7915–7922.
   PubMed Web of Science ®Google Scholar
• L. L. Dugan, D. M. Turetsky, C. Du, M. Wheeler, C. R. Almli, C. K. Shen, T. Y. Luh, D. W. Choi and T. S. Lin: ‘Carboxyfullerenes as neuroprotective agents’, Proc. Natl. Acad. Sci. U.S.A., 1997, 94, (17), 9434–9439.
   PubMed Web of Science ®Google Scholar
• L. L. Dugan, E. G. Lovett, K. L. Quick, J. Lotharius, T. T. Lin and K. L. O'Malley: ‘Fullerene-based antioxidants and neurodegenerative disorders’, Parkinsonism Relat. Disord., 2001, 7, (3), 243–246.
   PubMed Web of Science ®Google Scholar
• L. L. Dugan, L. Tian, K. L. Quick, J. I. Hardt, M. Karimi, C. Brown, S. Loftin, H. Flores, S. M. Moerlein, J. Polich, S. D. Tabbal, J. W. Mink and J. S. Perlmutter: ‘Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates’, Ann. Neurol., 2014, 76, (3), 393–402.
   PubMed Web of Science ®Google Scholar
• P. Witte, F. Beuerle, U. Hartnagel, R. Lebovitz, A. Savouchkina, S. Sali, D. Guldi, N. Chronakis and A. Hirsch: ‘Water solubility, antioxidant activity and cytochrome C binding of four families of exohedral adducts of C60 and C70’, Org. Biomol. Chem., 2007, 5, (22), 3599–3613.
   PubMed Web of Science ®Google Scholar
• J. J. Yin, F. Lao, P. P. Fu, W. G. Wamer, Y. Zhao, P. C. Wang, Y. Qiu, B. Sun, G. Xing, J. Dong, X. J. Liang and C. Chen: ‘The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials’, Biomaterials, 2009, 30, (4), 611–621.
   PubMed Web of Science ®Google Scholar
• Q. Liu, L. Jin, B. H. Mahon, M. D. Chordia, F. H. Shen and X. Li: ‘Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles’, Spine, 2013, 38, (17), 1443–1451.
   PubMed Web of Science ®Google Scholar
• F. Stewart, P. Baas and W. Star: ‘What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?’, Radiother. Oncol., 1998, 48, (3), 233–248.
   PubMed Web of Science ®Google Scholar
• F. Wilkinson, W. P. Helman and A. B. Ross: ‘Quantum yields for the photosensitized formation of the lowest electronically excited singlet state of molecular oxygen in solution’, J. Phys. Chem. Ref. Data, 1993, 22, (1993), 113.
   Web of Science ®Google Scholar
• S. Wang, R. Gao, F. Zhou and M. Selke: ‘Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy’, J. Mater. Chem., 2004, 14, (4), 487.
   Web of Science ®Google Scholar
• J. W. Arbogast, A. P. Darmanyan, C. S. Foote, Y. Rubin, F. N. Diederich, M. M. Alvarez, S. J. Anz and R. L. Whetten: ‘Photophysical properties of C60’, J. Phys. Chem., 1991 (95), 11–12.
   Web of Science ®Google Scholar
• T. Hamano, K. Okuda, T. Mashino, M. Hirobe, K. Arakane, A. Ryu, S. Mashiko and T. Nagano: ‘Singlet oxygen production from fullerene derivatives: effect of sequential functionalization of the fullerene core’, Chem. Commun., 1997, 21–22.
   Web of Science ®Google Scholar
• Y. Yamakoshi, N. Umezawa, A. Ryu, K. Arakane, N. Miyata, Y. Goda, T. Masumizu and T. Nagano: ‘Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-• versus 1O2’, J. Am. Chem. Soc., 2003, 125, (42), 12803–12809.
   PubMed Web of Science ®Google Scholar
• P. Mroz, G. P. Tegos, H. Gali, T. Wharton, T. Sarna and M. R. Hamblin: ‘Fullerenes as photosensitizers in photodynamic therapy’ in ‘Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes’, (ed. F. Cataldo and T. Da Ros), Vol. 1, chap. 4, 79–106; 2008, Berlin, Springer Science+Business Media.
   Google Scholar
• S.-G. Kang, G. Zhou, P. Yang, Y. Liu, B. Sun, T. Huynh, H. Meng, L. Zhao, G. Xing, C. Chen, Y. Zhao and R. Zhou: ‘Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine’, Proc. Natl. Acad. Sci., 2012, 109, (38), 15431–15436.
   PubMed Web of Science ®Google Scholar
• Y. Pan, L. Wang, S.-G. Kang, Y. Lu, Z. Yang, T. Huynh, C. Chen, R. Zhou, M. Guo and Y. Zhao: ‘Gd-metallofullerenol nanomaterial suppresses pancreatic cancer metastasis by inhibiting the interaction of histone deacetylase 1 and metastasis-associated protein 1’, ACS Nano, 2015, 9, (7), 6826–6836.
   PubMed Web of Science ®Google Scholar
• Y. Liu, C. Chen, P. Qian, X. Lu, B. Sun, X. Zhang, L. Wang, X. Gao, H. Li, Z. Chen, J. Tang, W. Zhang, J. Dong, R. Bai, P. E. Lobie, Q. Wu, S. Liu, H. Zhang, F. Zhao, M. S. Wicha, T. Zhu and Y. Zhao: ‘Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor’, Nat. Commun., 2015, 6, 5988.
   PubMed Web of Science ®Google Scholar
• C. Chen, G. Xing, J. Wang, Y. Zhao, B. Li, J. Tang, G. Jia, T. Wang, J. Sun, L. Xing, H. Yuan, Y. Gao, H. Meng, Z. Chen, F. Zhao, Z. Chai and X. Fang: ‘Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity’, Nano Lett., 2005, 5, (10), 2050–2057.
   PubMed Web of Science ®Google Scholar
• Z. Chen, L. Ma, Y. Liu and C. Chen: ‘Applications of functionalized fullerenes in tumor theranostics’, Theranostics, 2012, 2, (3), 238–250.
   PubMed Web of Science ®Google Scholar
• S. S. Kelkar and T. M. Reineke: ‘Theranostics: combining imaging and therapy’, Bioconjug. Chem., 2011, 22, 1879–1903.
   PubMed Web of Science ®Google Scholar
• E.-K. Lim, T. Kim, S. Paik, S. Haam, Y.-M. Huh and K. Lee: ‘Nanomaterials for theranostics: recent advances and future challenges’, Chem. Rev., 2015, 115, (1), 327–394.
   PubMed Web of Science ®Google Scholar
• V. Krishna, A. Singh, P. Sharma, N. Iwakuma, Q. Wang, Q. Zhang, J. Knapik, H. Jiang, S. R. Grobmyer, B. Koopman and B. Moudgil: ‘Polyhydroxy fullerenes for non-invasive cancer imaging and therapy’, Small, 2010, 6, (20), 2236–2241.
   PubMed Web of Science ®Google Scholar
• M. D. Shultz, J. D. Wilson, C. E. Fuller, J. Zhang, H. C. Dorn and P. P. Fatouros: ‘Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model’, Radiology, 2011, 261, (1), 136–143.
   PubMed Web of Science ®Google Scholar
• M. D. Shultz, J. C. Duchamp, J. D. Wilson, C. Y. Shu, J. Ge, J. Zhang, H. W. Gibson, H. L. Fillmore, J. I. Hirsch, H. C. Dorn and P. P. Fatouros: ‘Encapsulation of a radiolabeled cluster inside a fullerene cage, 177Lux Lu(3-x)N@C80: an interleukin-13-conjugated radiolabeled metallofullerene platform’, J. Am. Chem. Soc., 2010, 132, (14), 4980–4981.
   PubMed Web of Science ®Google Scholar
• E. B. Iezzi, J. C. Duchamp, K. R. Fletcher, T. E. Glass and H. C. Dorn: ‘Lutetium-based trimetallic nitride endohedral metallofullerenes: new contrast agents’, Nano Lett., 2002, 2, (11), 1187–1190.
   Web of Science ®Google Scholar
• J. Luo, J. D. Wilson, J. Zhang, J. I. Hirsch, H. C. Dorn, P. P. Fatouros and M. D. Shultz: ‘A dual PET/MR imaging nanoprobe: 124I Labeled Gd3N@C80’, Appl. Sci., 2012, 2, (2), 465–478.
   Google Scholar
• J. Potocnik: ‘On a code of conduct for responsible nanosciences and nanotechnologies research’, 2009, EUR 23906, ISBN 978-92-79-11605-6 Luxembourg, European Commission.
   Google Scholar
• V. Stone, S. Hankin, R. Aitken, K. Aschberger, A. Baun, F. M. Christense, T. F. Fernandes, S. F. Hansen, N. B. Hartmann, G. R. Hutchison, H. Johnson, C. Micheletti, S. Read, B. Ross, B. Sokull-Kluettgen, D. Stark and L. Tran: ‘ENRHES: Engineered nanoparticles: review of health and environmental safety’, 2010, Brussels, European Commission.
   Google Scholar
• G. Szekely, M. C. Amores de Sousa, M. Gil, F. Castelo Ferreira and W. Heggie: ‘Genotoxic impurities in pharmaceutical manufacturing: sources, regulations, and mitigation’, Chem. Rev., 2015, 115, (16), 8182–8229.
   PubMed Web of Science ®Google Scholar
• A. Sharma, S. V. Madhunapantula and G. P. Robertson: ‘Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems’, Expert Opin. Drug Metab. Toxicol., 2012, 8, 47–69.
   PubMed Web of Science ®Google Scholar
• E. A. Kyzyma, A. A. Tomchuk, L. A. Bulavin, V. I. Petrenko, L. Almasy, M. V. Korobov, D. S. Volkov, I. V. Mikheev, I. V. Koshlan, N. A. Koshlan, P. Blaha, M. V. Avdeev and V. L. Aksenov: ‘Structure and toxicity of aqueous fullerene C60 solutions’, J. Surf. Invest.: X-ray, Synchrotron Neutron Tech., 2015, 9, (1), 1–5.
   Google Scholar
• C. M. Sayes, J. D. Fortner, W. Guo, D. Lyon, A. M. Boyd, K. D. Ausman, Y. J. Tao, B. Sitharaman, L. J. Wilson, J. B. Hughes, J. L. West and V. L. Colvin: ‘The differential cytotoxicity of water-soluble fullerenes’, Nano Lett., 2004, 4, (10), 1881–1887.
   Web of Science ®Google Scholar
• J. Gao, Y. Wang, K. M. Folta, V. Krishna, W. Bai, P. Indeglia, A. Georgieva, H. Nakamura, B. Koopman and B. Moudgil: ‘Polyhydroxy fullerenes (fullerols or fullerenols): beneficial effects on growth and lifespan in diverse biological models’, PLoS ONE, 2011, 6, (5), 1–8.
   Web of Science ®Google Scholar
• A. Djordjevic and G. Bogdanovic: ‘Fullerenol: a new nanopharmaceutic?’, Arch. Oncol., 2008, 16, (3–4), 42–45.
   Google Scholar
• B. Srdjenovic, V. Milic-Torres, N. Grujic, K. Stankov, A. Djordjevic and V. Vasovic: ‘Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin’, Toxicol. Mech. Method, 2010, 20, (6), 298–305.
   PubMed Web of Science ®Google Scholar
• J. Fan, G. Fang, F. Zeng, X. Wang and F. Wu: ‘Water-dispersible fullerene aggregates as a targeted anticancer prodrug with both chemo- and photodynamic therapeutic actions’, Small, 2013, 9, 613–621.
   PubMed Web of Science ®Google Scholar
• K. K. Jain: ‘The handbook of nanomedicine’, 2nd edn, 2012, New York, Springer.
   Google Scholar
• J. Besley: ‘Current research on public perceptions of nanotechnology’, Emerg. Health Threats J., 2010, 3, e8.
   PubMedGoogle Scholar
• N. Pidgeon, B. H. Harthorn, K. Bryant and T. Rogers-Hayden, ‘Deliberating the risks of nanotechnologies for energy and health applications in the United States and United Kingdom’, Nat. Nanotechnol., 2009, 4, (2), 95–98.
   PubMed Web of Science ®Google Scholar
• M. Siegrist, A. Wiek, A. Helland and H. Kastenholz: ‘Risks and nanotechnology: the public is more concerned than experts and industry’, Nat. Nanotechnol., 2007, 2, (2), 67.
   PubMed Web of Science ®Google Scholar
• H. Rauscher, B. Sokull-Klüttgen and H. Stamm: ‘The European commission's recommendation on the definition of nanomaterial makes an impact’, Nanotoxicology, 2012, 7, 1–3.
   PubMed Web of Science ®Google Scholar
• R. H. Baughman, A. A. Zakhidov and W. A. de Heer: ‘Carbon nanotubes on the route toward applications’, Science, 2002, 297, 787.
   PubMed Web of Science ®Google Scholar
• H. Shen, L. Zhang, M. Liu and Z. Zhang: ‘Biomedical applications of graphene’, Theranostics, 2012, 2, (3), 283–294.
   PubMed Web of Science ®Google Scholar
• I. L. Medintz, H. Mattoussi and A. R. Clapp: ‘Potential clinical applications of quantum dots’, Int. J. Nanomed., 2008, 3, (2), 151–167.
   PubMed Web of Science ®Google Scholar
• M. Mahmoudi, S. Sant, B. Wang, S. Laurent and T. Sen: ‘Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy’,Adv. Drug Deliv. Rev., 2011, 63, (1–2), 24–46.
   PubMed Web of Science ®Google Scholar